Treat Now or Later in HCV? Expert Guidance for Individual Scenarios

Ira M. Jacobson, MD, reviews key clinical data underpinning the decision to treat or wait in HCV and several specific cases patient scenarios in a CME-certified Interactive Virtual Presentation and is then joined by Paul Y. Kwo, MD; Andrew J. Muir, MD, MHS; Mark S. Sulkowski, MD; and Norah Terrault, MD, MPH, to provide management recommendations based on patient and disease characteristics entered by the participant.

Interactive Virtual Presentation

Ira Jacobson, MD, reviews the key factors in deciding to treat or wait in HCV, then walks through several patient scenarios.

Released: December 20, 2013
Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)

Educational grant provided by:
Boehringer Ingelheim Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?